CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Deferred Compensation	Retained Earnings (Deficit)	Accumulated Other Comprehensive (Loss)	Treasury Stock
Beginning balance (in shares) at Feb. 01, 2020		14,762
Beginning balance at Feb. 01, 2020	$ 235,187	$ 1,476	$ 139,041	$ 2,956	$ 108,215	$ (13,545)	$ (2,956)
Beginning balance, treasury stock (in shares) at Feb. 01, 2020							(51)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		173
Vesting of stock awards	0	$ 17	(17)
Stock-based compensation expense	14,316		14,316
Purchase and retirement of shares (in shares)		(294)
Purchase and retirement of common stock	(15,490)	$ (29)	(4,821)		(10,640)
Other comprehensive loss	(271)					(271)
Other comprehensive loss	477
Deferral of common stock into deferred compensation plan	0			209			$ (209)
Deferral of common stock into deferred compensation plan (in shares)							(6)
Net income (loss)	(140,365)				(140,365)
Ending balance (in shares) at Jan. 30, 2021		14,641
Ending balance at Jan. 30, 2021	93,377	$ 1,464	148,519	3,165	(42,790)	(13,816)	$ (3,165)
Ending balance, treasury stock (in shares) at Jan. 30, 2021							(57)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		348
Vesting of stock awards	0	$ 35	(35)
Stock-based compensation expense	30,942		30,942
Purchase and retirement of shares (in shares)		(1,025)
Purchase and retirement of common stock	(85,648)	$ (103)	(19,078)		(66,467)
Other comprehensive loss	(370)					(370)
Deferral of common stock into deferred compensation plan	0			278			$ (278)
Deferral of common stock into deferred compensation plan (in shares)							(4)
Net income (loss)	$ 187,171				187,171
Ending balance (in shares) at Jan. 29, 2022	13,903	13,964
Ending balance at Jan. 29, 2022	$ 225,472	$ 1,396	160,348	3,443	77,914	(14,186)	$ (3,443)
Ending balance, treasury stock (in shares) at Jan. 29, 2022							(61)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		281
Vesting of stock awards	0	$ 28	(28)
Stock-based compensation expense	29,150		29,150
Purchase and retirement of shares (in shares)		(1,953)
Purchase and retirement of common stock	(92,945)	$ (195)	(38,514)		(54,236)
Other comprehensive loss	(2,061)					(2,061)
Deferral of common stock into deferred compensation plan	0			293			$ (293)
Deferral of common stock into deferred compensation plan (in shares)							(6)
Net income (loss)	$ (1,138)				(1,138)
Ending balance (in shares) at Jan. 28, 2023	12,225	12,292
Ending balance at Jan. 28, 2023	$ 158,478	$ 1,229	$ 150,956	$ 3,736	$ 22,540	$ (16,247)	$ (3,736)
Ending balance, treasury stock (in shares) at Jan. 28, 2023							(67)